首页> 外文会议>Portland International Conference on Management of Engineering and Technology >Venture Capital and Patent Activities in China--Multi-case Study in Bio-pharmaceutical Industry
【24h】

Venture Capital and Patent Activities in China--Multi-case Study in Bio-pharmaceutical Industry

机译:中国风险投资与专利活动 - 生物制药业的多案例研究

获取原文
获取外文期刊封面目录资料

摘要

Patents signal a start-up's technological and innovative capability. Venture Capital (VC) investors can evaluate the true potential and behavior of start-ups through their patents. While, VC would have effect in enterprises' innovation output. The detailed interaction between VC and patent activities in China is different and attractive. This paper tries to explore this relationship in two levels, describing the overall investment of China as descriptive analysis and multi-case study as exploratory analysis. We first got a full-view perspective of VC investments amount and industry distribution in China. Then we looked into 57 companies in bio-pharmaceutical industry and divided them into four groups, already in a good track when getting VCs, holding patents when the companies are founded, getting innovation (patents) by mergers and acquisitions, and don't care patents much. By analyzing the interaction between VC and patent activities of four typical companies, we got four characteristics, which could be referenced by both companies and investors in making decisions.
机译:专利表示启动的技术和创新能力。风险投资(VC)投资者可以通过他们的专利来评估初创企业的真正潜力和行为。虽然,VC将对企业的创新产出产生影响。中国的VC与专利活动之间的详细互动是不同和有吸引力的。本文试图在两个层面中探讨这种关系,描述了中国的整体投资作为描述性分析和多种研究作为探索性分析。我们首先在中国的VC Investments数量和行业分布的全面视角。然后,我们研究了生物制药行业的57家公司,并将他们分成了四组,在获得VCS时已经在一个很好的轨道上,持有专利在公司成立时,通过合并和收购获得创新(专利),并不关心专利很多。通过分析四家典型公司的VC与专利活动之间的互动,我们得到了四种特征,可以由公司和投资者参考决定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号